Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $13.7 million.

  • Rockwell Medical's Cost of Revenue fell 3814.83% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.1 million, marking a year-over-year decrease of 2197.85%. This contributed to the annual value of $84.0 million for FY2024, which is 1214.42% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Cost of Revenue is $13.7 million, which was down 3814.83% from $13.6 million recorded in Q2 2025.
  • Rockwell Medical's Cost of Revenue's 5-year high stood at $22.1 million during Q3 2024, with a 5-year trough of $13.6 million in Q2 2025.
  • In the last 5 years, Rockwell Medical's Cost of Revenue had a median value of $17.0 million in 2023 and averaged $17.6 million.
  • As far as peak fluctuations go, Rockwell Medical's Cost of Revenue surged by 2484.31% in 2024, and later tumbled by 3814.83% in 2025.
  • Rockwell Medical's Cost of Revenue (Quarter) stood at $17.6 million in 2021, then fell by 3.36% to $17.0 million in 2022, then grew by 13.26% to $19.2 million in 2023, then increased by 9.42% to $21.0 million in 2024, then tumbled by 35.08% to $13.7 million in 2025.
  • Its Cost of Revenue was $13.7 million in Q3 2025, compared to $13.6 million in Q2 2025 and $15.9 million in Q1 2025.